Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to…
Read More
New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients
New guidelines from the American Society of Hematology “strongly recommend” using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, and using no thromboprophylaxis over oral thromboprophylaxis with vitamin K…
Read More
Amlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More
Protamine Sulphate
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PROTAMINE SULFATE® Injection 1% CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about PROTAMINE SULFATE. It does not contain all the…
Read More
Estalis Continuous
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ESTALIS® CONTINUOUS estradiol / norethisterone acetate (NETA) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about the menopause (the “change of…
Read More
Aromasin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AROMASIN® Exemestane Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AROMASIN. It does not contain all the available information.It does…
Read More
Minirin Injection
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MINIRIN® Injection desmopressin acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MINIRIN Injection. It does not contain all the…
Read More
APO-Ramipril Tablets
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-RAMIPRIL TABLETS Ramipril Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ramipril. It does not contain all the available information….
Read More